首页> 外文期刊>Cardiovascular Diabetology >Global gene expression profiling displays a network of dysregulated genes in non-atherosclerotic arterial tissue from patients with type 2 diabetes
【24h】

Global gene expression profiling displays a network of dysregulated genes in non-atherosclerotic arterial tissue from patients with type 2 diabetes

机译:全局基因表达谱显示来自2型糖尿病患者的非动脉粥样硬化动脉组织中基因失调的网络

获取原文
           

摘要

Background Generalized arterial alterations, such as endothelial dysfunction, medial matrix accumulations, and calcifications are associated with type 2 diabetes (T2D). These changes may render the vessel wall more susceptible to injury; however, the molecular characteristics of such diffuse pre-atherosclerotic changes in diabetes are only superficially known. Methods To identify the molecular alterations of the generalized arterial disease in T2D, DNA microarrays were applied to examine gene expression changes in normal-appearing, non-atherosclerotic arterial tissue from 10 diabetic and 11 age-matched non-diabetic men scheduled for a coronary by-pass operation. Gene expression changes were integrated with GO-Elite, GSEA, and Cytoscape to identify significant biological pathways and networks. Results Global pathway analysis revealed differential expression of gene-sets representing matrix metabolism, triglyceride synthesis, inflammation, insulin signaling, and apoptosis. The network analysis showed a significant cluster of dysregulated genes coding for both intra- and extra-cellular proteins associated with vascular cell functions together with genes related to insulin signaling and matrix remodeling. Conclusions Our results identify pathways and networks involved in the diffuse vasculopathy present in non-atherosclerotic arterial tissue in patients with T2D and confirmed previously observed mRNA-alterations. These abnormalities may play a role for the arterial response to injury and putatively for the accelerated atherogenesis among patients with diabetes.
机译:背景技术广泛的动脉改变,例如内皮功能障碍,内侧基质蓄积和钙化,均与2型糖尿病(T2D)相关。这些变化可能使血管壁更容易受伤。然而,这种弥散性的糖尿病前动脉粥样硬化改变的分子特征只是表面上的了解。方法为了确定T2D中广泛性动脉疾病的分子变化,使用DNA芯片检测了10名糖尿病患者和11名年龄匹配的非糖尿病男性的正常表象,非动脉粥样硬化的动脉组织中的基因表达变化。 -pass操作。基因表达变化与GO-Elite,GSEA和Cytoscape整合在一起,以鉴定重要的生物学途径和网络。结果全局途径分析揭示了代表基质代谢,甘油三酸酯合成,炎症,胰岛素信号传导和细胞凋亡的基因集的差异表达。网络分析表明,大量失调的基因编码与血管细胞功能相关的细胞内和细胞外蛋白,以及与胰岛素信号传导和基质重塑相关的基因。结论我们的结果确定了T2D患者非动脉粥样硬化动脉组织中存在的弥漫性血管病变的途径和网络,并证实了先前观察到的mRNA改变。这些异常可能对动脉的损伤反应有影响,并且可能对糖尿病患者的动脉粥样硬化加速发展有影响。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号